Skip to main content

Advertisement

Log in

New tungstenocenes containing 3-hydroxy-4-pyrone ligands: antiproliferative activity on HT-29 and MCF-7 cell lines and binding to human serum albumin studied by fluorescence spectroscopy and molecular modeling methods

  • Original Paper
  • Published:
JBIC Journal of Biological Inorganic Chemistry Aims and scope Submit manuscript

Abstract

Three new water-soluble tungstenocene derivatives were synthesized and characterized using 3-hydroxy-4-pyrone ligands, which provide aqueous stability to the complexes. The antiproliferative activities of the complexes on HT-29 colon cancer and MCF-7 breast cancer cell lines were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and showed the new tungstenocene derivatives have higher antiproliferative action than tungstenocene dichloride (Cp2WCl2, where Cp is cyclopentadienyl). The binding interactions of the tungstenocenes with human serum albumin (HSA) were investigated using fluorescence spectroscopy and molecular modeling methods. Analysis of the fluorescence quenching spectra indicates that the tungstenocene complexes bind HSA by hydrophobic interactions and hydrogen bonding at fatty acid binding site 6 and drug binding site II. Docking studies provided a description of the hydrophobic interactions and hydrogen bonding by which the tungstenocenes become engaged with HSA. It was determined that the binding affinity of the tungstenoecenes for HSA is in the order Cp2WCl2 < [Cp2W(ethyl maltolato)]Cl < [Cp2W(maltolato)]Cl < [Cp2W(kojato)]Cl, consistent with the hydrophobic interactions and the number of hydrogen bonds involved.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Jaouen G (ed) (2006) Bioorganometallics. Wiley, Weinheim

    Google Scholar 

  2. Jaouen G, Metzler-Nolte N (eds) (2010) Medicinal Organometallic Chemistry. Springer, Heidelberg

    Google Scholar 

  3. Gasser G, Ott I, Metzler-Nolte N (2011) J Med Chem 54:3

    Article  PubMed  CAS  Google Scholar 

  4. Köpf H, Köpf-Maier P (1979) Angew Chem Int Ed Engl 18:477

    Article  PubMed  Google Scholar 

  5. Köpf-Maier P (1994) Eur J Clin Pharmacol 47:1

    Article  PubMed  Google Scholar 

  6. Köpf-Maier P, Köpf H (1988) Struct Bond 70:103

    Article  Google Scholar 

  7. Köpf-Maier P, Köpf H (1987) Chem Rev 87:137

    Google Scholar 

  8. Köpf-Maier P, Köpf H (1994) In: Fricker SP (ed) Metal Compounds in Cancer Therapy, Organometallic Titanium, Vanadium, Niobium, Molybdenu and Rhenium Complexes - Early Transition Metal Antitumor Drugs. Chapman and Hall, London, pp 109–146

    Google Scholar 

  9. Harding MM, Mokdsi G (2000) Curr Med Chem 7:1289

    Article  PubMed  CAS  Google Scholar 

  10. Meléndez E (2002) Crit Rev Oncol Hematol 42:309

    Article  PubMed  Google Scholar 

  11. Abeysinghe PM, Harding MM (2007) Dalton Trans 32:3472

    Google Scholar 

  12. Meléndez E (2012) J Organomet Chem 706–707:4

    Article  PubMed  Google Scholar 

  13. Berdel WE, Schmoll H-J, Scheulen ME, Korfel A, Knoche MF, Harstrick A, Bach F, Baumgart J, Saβ G (1994) J Cancer Res Clin Oncol 120(Supp):R172

    Google Scholar 

  14. Korfel A, Scheulen ME, Schmoll H-J, Gründel O, Harstrick A, Knoche M, Fels LM, Skorzec M, Bach F, Baumgart J, Saβ G, Seeber S, Thiel E, Berdel W (1998) Clin Cancer Res 4:2701

    Google Scholar 

  15. Luemmen G, Sperling H, Luboldt H, Otto T, Ruebben H (1998) Cancer Chemother Pharmacol 42:415

    Article  CAS  Google Scholar 

  16. Christodoulou CV, Ferry DR, Fyfe DW, Young A, Doran J, Sheehan TMT, Eliopoulos A, Hale K, Baumgart J, Sass G, Kerr DJ (1998) J Clin Oncol 16:2761

    PubMed  CAS  Google Scholar 

  17. Kröger N, Kleeberg UR, Mross K, Sass G, Hossfeld DK (2000) Onkologie 23:60

    Article  Google Scholar 

  18. Baumgart J, Berdel WE, Fiebig H, Unger C (2000) Onkologie 23:576

    Article  PubMed  Google Scholar 

  19. Kopf-Maier P (1980) J Inorg Nucl Chem 42:1789

    Article  Google Scholar 

  20. Campell KS, Dillon CT, Smith SV, Harding MM (2007) Polyhedron 26:456

    Article  Google Scholar 

  21. Feliciciano I, Matta J, Meléndez E (2009) J Biol Inorg Chem 14:1109

    Article  Google Scholar 

  22. Acevedo-Acevedo D, Matta J, Meléndez E (2011) J Organomet Chem 696:1032

    Article  PubMed  CAS  Google Scholar 

  23. Waern JB, Dillon CT, Harding MM (2005) J Med Chem 48:2093

    Article  PubMed  CAS  Google Scholar 

  24. Gleeson B, Claffey J, Hogan M, Müller-Bunz H, Wallis D, Tacke M (2010) Inorg Chim Acta 363:1831

    Article  CAS  Google Scholar 

  25. Ahmet MT, Frampton CS, Silver J (1988) J Chem Soc Dalton Trans 1159

  26. Finnegan MM, Rettig SJ, Orvig C (1986) J Am Chem Soc 108:5033

    Article  CAS  Google Scholar 

  27. Nelson WO, Karpishin TB, Rettig SJ, Orvig C (1988) Inorg Chem 27:1045

    Article  CAS  Google Scholar 

  28. Yu P, Phillips BL, Olmstead MM, Casey WH (2002) J Chem Soc Dalton Trans 2119

  29. Saatchi K, Thompson KH, Patrick BO, Pink M, Yuen VG, McNeill JH, Orvig C (2005) Inorg Chem 44:2689

    Article  PubMed  CAS  Google Scholar 

  30. Thompson KH, McNeill JH, Orvig C (1999) Chem Rev 99:2561

    Article  PubMed  CAS  Google Scholar 

  31. Vera JL, Román FR, Meléndez E (2006) Biorg Med Chem 14:8683

    Article  CAS  Google Scholar 

  32. Kotz JC, Vining W, Coco W, Rosen R, Dias AR, Garcia MH (1983) Organometallics 2:68

    Article  CAS  Google Scholar 

  33. Mossman T (1983) J Immunol Methods 65:55

    Article  Google Scholar 

  34. Denizot F, Lang R (1986) J Immunol Methods 89:271

    Article  PubMed  CAS  Google Scholar 

  35. Köpf-Maier P, Köpf H (1984) J Cancer Res Clin Oncol 108:336

    Article  PubMed  Google Scholar 

  36. Vera J, Gao LM, Santana A, Matta J, Meléndez E (2011) Dalton Trans 40:9957

    Article  Google Scholar 

  37. Vessières A, Top S, Beck W, Hillard E, Jaouen G (2006) Dalton Trans 529

  38. Vessières A, Plamont M-A, Cabestaing C, Claffey J, Dieckmann S, Hogan M, Müller-Bunz H, Strohfeldt K, Tacke M (2009) J Organomet Chem 694:874

    Article  Google Scholar 

  39. Top S, Kaloun EB, Vessières A, Laïos I, Leclercq G, Jaouen G (2002) J Organomet Chem 643:350

    Article  Google Scholar 

  40. Dugaiczyk A, Law SW, Dennison OE (1982) Proc Natl Acad Sci USA 79:71

    Article  PubMed  CAS  Google Scholar 

  41. He XM, Carter DC (1992) Nature 358:209

    Article  PubMed  CAS  Google Scholar 

  42. Tang J, Liam N, He X, Zhang G (2008) J Mol Struct 889:408

    Article  CAS  Google Scholar 

  43. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999) Protien Eng 12:439

    Article  CAS  Google Scholar 

  44. Lu Y, Feng Q, Cui F, Xing W, Zhang G, Yao X (2010) Bioorg Med Chem Lett 20:6899

    Article  PubMed  CAS  Google Scholar 

  45. Sułkowska A, Bojko B, Rownicka J, Sułkowski WW (2006) J Mol Struct 792–793:249

    Article  Google Scholar 

  46. Tian J, Liu J, Xie J, Yao X, Hu Z, Chen X (2004) J Photochem Photobiol B Biolo 74:39

    Article  CAS  Google Scholar 

  47. Guo X, Sun X, Xu S (2009) J Mol Struct 931:55

    Article  CAS  Google Scholar 

  48. Cui F, Fan J, Lib J, Hu Z (2004) Bioorg Med Chem 12:151

    Article  PubMed  CAS  Google Scholar 

  49. Lakowicz J (2006) Principles of fluorescence spectroscopy, 3rd edn. Springer, New York

  50. Huang YB, Liu BZ, Yu Z, Gao XY, Zi YQ (2010) J Lumin 130(3):360

    Article  CAS  Google Scholar 

  51. Ross P, Subramanian S (1981) Biochemistry 20:3096

    Article  PubMed  CAS  Google Scholar 

  52. Zhang G, Ma Y, Wang L, Zhang Y, Zhou J (2012) Food Chem 133:264

    Article  CAS  Google Scholar 

  53. Curry S (2011) In: Otagiri M (ed) Human serum albumin—new insights on its structural dynamics, functional impacts and pharmaceutical applications. Sojo University Publishing Center, Kumamoto, pp 1–20

  54. Tripos International SYBYL 8.1. Tripos International, St Louis

  55. Jain AN (2003) J Med Chem 46:499

    Article  PubMed  CAS  Google Scholar 

  56. Sarsam SW, Nutt DR, Strohfeldt K, Watson KA (2011) Metallomics 3:152

    Article  PubMed  CAS  Google Scholar 

  57. Frisch MJ et al (2003) Gaussian 03, revision B.04. Gaussian, Pittsburgh

Download references

Acknowledgments

E.M. acknowledges the NIH-MBRS SCORE program at the University of Puerto Rico Mayagüez for financial support via NIH-MBRS-SCORE program grant S06 GM008103-37. We are grateful to Jesús Olivero-Verbel from the University of Cartagena, Colombia, for allowing us to use the program SYBIL and for revising the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Enrique Meléndez.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 4004 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Domínguez-García, M., Ortega-Zúñiga, C. & Meléndez, E. New tungstenocenes containing 3-hydroxy-4-pyrone ligands: antiproliferative activity on HT-29 and MCF-7 cell lines and binding to human serum albumin studied by fluorescence spectroscopy and molecular modeling methods. J Biol Inorg Chem 18, 195–209 (2013). https://doi.org/10.1007/s00775-012-0964-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00775-012-0964-2

Keywords

Navigation